Ladenburg Thalmann Financial Services’s Abeona Therapeutics ABEO Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Hold	0	–	–	–	5304
2019 Q3	–	Sell	-4	Closed	-$300	–	5251
2019 Q2	$0	Hold	4	–	–	﹤0.01%	5248
2019 Q1	$1K	Hold	4	–	–	﹤0.01%	5032
2018 Q4	$1K	Hold	4	–	–	﹤0.01%	4997
2018 Q3	$1K	Sell	4 -38	-90%	-$13.5K	﹤0.01%	4956
2018 Q2	$15K	Hold	42	–	–	﹤0.01%	3993
2018 Q1	$15K	Buy	42 +34	+425%	+$12.6K	﹤0.01%	3993
2017 Q4	$3K	Buy	+8	New	+$3.31K	﹤0.01%	4658
2017 Q3	–	Sell	-40	Closed	-$6K	–	4913
2017 Q2	$6K	Hold	40	–	–	﹤0.01%	4234
2017 Q1	$5K	Hold	40	–	–	﹤0.01%	4281
2016 Q4	$5K	Hold	40	–	–	﹤0.01%	4203
2016 Q3	$6K	Hold	40	–	–	﹤0.01%	4050
2016 Q2	$2K	Hold	40	–	–	﹤0.01%	4367
2016 Q1	$3K	Hold	40	–	–	﹤0.01%	4241
2015 Q4	$3K	Hold	40	–	–	﹤0.01%	4211
2015 Q3	$4K	Hold	40	–	–	﹤0.01%	4006
2015 Q2	$5K	Buy	+40	New	+$6.01K	﹤0.01%	4026

Other funds holding ABEO

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ABEO Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Abeona Therapeutics (ABEO) position steady in Q4 2019 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5304.

Ladenburg Thalmann Financial Services first reported a position in ABEO in Q2 2015 and has held it in 16 quarters since. The position peaked at $15K in Q2 2018. 87 funds tracked by Wall St. Rank hold ABEO as of Q4 2019.

Ladenburg Thalmann Financial Services held 0 shares of Abeona Therapeutics worth $0 as of Q4 2019.
Ladenburg Thalmann Financial Services left its Abeona Therapeutics share count unchanged in Q4 2019.
Abeona Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5304 holding.
Ladenburg Thalmann Financial Services first reported a position in Abeona Therapeutics in Q2 2015 and has held it in 16 quarters since.
Ladenburg Thalmann Financial Services's Abeona Therapeutics position peaked at $15K in Q2 2018.
87 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.